1. Home
  2. CIM vs MGTX Comparison

CIM vs MGTX Comparison

Compare CIM & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chimera Investment Corporation

CIM

Chimera Investment Corporation

HOLD

Current Price

$10.35

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$10.92

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIM
MGTX
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
CIM
MGTX
Price
$10.35
$10.92
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$15.25
★ $24.57
AVG Volume (30 Days)
★ 1.0M
824.2K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
★ 10.92%
N/A
EPS Growth
★ 56.36
33.02
EPS
N/A
★ 1.30
Revenue
N/A
★ $81,391,000.00
Revenue This Year
$1.62
$141.38
Revenue Next Year
$2.48
N/A
P/E Ratio
★ N/A
$8.50
Revenue Growth
N/A
★ 144.57
52 Week Low
$10.38
$6.62
52 Week High
$14.18
$15.35

Technical Indicators

Market Signals
Indicator
CIM
MGTX
Relative Strength Index (RSI) 25.46 25.95
Support Level N/A $8.84
Resistance Level $13.77 $11.85
Average True Range (ATR) 0.23 0.56
MACD -0.04 -0.28
Stochastic Oscillator 10.54 6.66

Price Performance

Historical Comparison
CIM
MGTX

About CIM Chimera Investment Corporation

Chimera Investment Corporation is an internally managed REIT whose principal business objective is to provide attractive risk-adjusted returns and distributable income through investment performance linked to mortgage credit fundamentals. Through its mortgage lending, investment management, and advisory services platforms, the Company operates as a fully integrated mortgage business that originates, manages, and invests in a diversified range of mortgage assets. The Company invests, directly or indirectly, generally on a levered basis across a spectrum of mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, MSRs, business purpose and investor loans, including RTLs, and other real estate-related assets.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: